Many cannabis stocks have experienced significant growth over the past six months. For instance, shares of Tilray Brands ...

Still, Trump’s order was a positive step for marijuana stocks, Seaport Research Partners argued in a research note. The firm saw Thursday’s pullback as a “textbook ‘sell-the-news’ reaction” driven in ...

Aurora Cannabis faces uneven gains from marijuana reclassification as medical cannabis drives growth, while weak consumer ...

In December, President Donald Trump in an executive order told his attorney general to expediate a rulemaking process related to rescheduling marijuana as a less-dangerous drug.

U.S. cannabis stocks appear to have completed their post-Executive Order pullback, says Beacon Securities analyst Russell ...

Recent regulatory developments have improved the landscape of the cannabis industry in the U.S. Canopy Growth and Aurora ...

Analysts covering the sector have turned more constructive on cannabis stocks, citing improved regulatory clarity and ...

Cannabis stocks are up on reports that the government could reclassify the drug. Tilray, Cronos, and Canopy Growth all spiked on the news. It's not the first time regulatory hopes have driven big ...

After logging a 1.6% gain during regular trading hours today, Tilray Brands ( TLRY +1.56%) is racing higher in after-hours ...